[{"NetIncomeLoss_1_Q3_USD":-20437000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":5824000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_3_Q3_shares":39714490.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q3_shares":44156808.0,"CommitmentsAndContingencies_0_Q3_USD":null,"PaidInKindInterest_3_Q3_USD":276000.0,"LiabilitiesNoncurrent_0_Q3_USD":32175000.0,"InterestPaidNet_3_Q3_USD":1133000.0,"PaymentsToAcquireShortTermInvestments_3_Q3_USD":150350000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-78390000.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":2000.0,"AssetsCurrent_0_Q3_USD":177432000.0,"OtherNoncashIncomeExpense_3_Q3_USD":-2000.0,"DepositsAssetsCurrent_0_Q3_USD":5567000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":1707000.0,"ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities_3_Q3_USD":71960000.0,"CommonStockSharesIssued_0_Q3_shares":38834381.0,"AvailableForSaleSecuritiesDebtSecurities_0_Q3_USD":113803000.0,"Assets_0_Q3_USD":179309000.0,"ShareBasedCompensation_3_Q3_USD":7022000.0,"OperatingLeaseRightOfUseAsset_0_Q3_USD":396000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths_0_Q3_USD":2285000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.001,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"GeneralAndAdministrativeExpense_3_Q3_USD":17787000.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_1_Q3_USD":-64000.0,"OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax_3_Q3_USD":53000.0,"LongTermLoansPayable_0_Q3_USD":20006000.0,"ShortTermInvestments_0_Q3_USD":113803000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":34913000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":14408000.0,"ProceedsFromStockPlans_3_Q3_USD":242000.0,"OtherNonoperatingIncomeExpense_3_Q3_USD":-186000.0,"OtherNonoperatingIncomeExpense_1_Q3_USD":-126000.0,"CommonStockValue_0_Q3_USD":4000.0,"Supplies_0_Q3_USD":145000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":165766000.0,"UnamortizedDebtIssuanceExpense_0_Q3_USD":211000.0,"InterestReceivableCurrent_0_Q3_USD":228000.0,"OtherPrepaidExpenseCurrent_0_Q3_USD":320000.0,"AccruedLiabilitiesAndOtherLiabilities_0_Q3_USD":9431000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_3_Q3_USD":-56641000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q3_USD":-20437000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-52682000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":-20501000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":-2342000.0,"OtherAssetsNoncurrent_0_Q3_USD":1267000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":56356000.0,"OperatingLeaseLiabilityNoncurrent_0_Q3_USD":172000.0,"AdditionalPaidInCapitalCommonStock_0_Q3_USD":680125000.0,"Liabilities_0_Q3_USD":47332000.0,"DebtSecuritiesAvailableForSaleRealizedGainLoss_3_Q3_USD":0.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":5789000.0,"CommonStockSharesAuthorized_0_Q3_shares":100000000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":1138000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-548205000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":31747000.0,"CommonStockSharesOutstanding_0_Q3_shares":38834381.0,"AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":55000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":3063000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":-55629000.0,"LiabilitiesCurrent_0_Q3_USD":15157000.0,"AccountsPayableCurrent_0_Q3_USD":3836000.0,"NonoperatingIncomeExpense_3_Q3_USD":-1173000.0,"NonoperatingIncomeExpense_1_Q3_USD":-584000.0,"InterestExpense_3_Q3_USD":1722000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":195000.0,"InterestExpense_1_Q3_USD":635000.0,"ProceedsFromStockOptionsExercised_3_Q3_USD":3060000.0,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":470000.0,"AccumulatedOtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax_0_Q3_USD":53000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":56471000.0,"ProceedsFromDebtNetOfIssuanceCosts_3_Q3_USD":19730000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_3_Q3_shares":311871.0,"NumberOfOperatingSegments_3_Q3_Segment":1.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo_0_Q3_USD":9727000.0,"PrepaidInsurance_0_Q3_USD":896000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":214000.0,"NetIncomeLoss_3_Q3_USD":-52735000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":7158000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":-1138000.0,"AvailableForSaleDebtSecuritiesAmortizedCostBasis_0_Q3_USD":113750000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q3_USD":11995000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":379000.0,"AdjustmentToAdditionalPaidInCapitalIncomeTaxEffectFromShareBasedCompensationNet_1_Q3_USD":94000.0,"OperatingIncomeLoss_3_Q3_USD":-51562000.0,"OperatingIncomeLoss_1_Q3_USD":-19853000.0,"InvestmentIncomeInterest_3_Q3_USD":735000.0,"InvestmentIncomeInterest_1_Q3_USD":177000.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":1517000.0,"PreferredStockValue_0_Q3_USD":null,"LiabilitiesAndStockholdersEquity_0_Q3_USD":179309000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":2760000.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"DebtInstrumentCarryingAmount_0_Q3_USD":20000000.0,"LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree_0_Q3_USD":7988000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":3063000.0,"OperatingLeaseLiabilityCurrent_0_Q3_USD":373000.0,"OperatingExpenses_3_Q3_USD":52700000.0,"OperatingExpenses_1_Q3_USD":20232000.0,"IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities_3_Q3_USD":-1119000.0,"RestrictedCashAndCashEquivalentsAtCarryingValue_0_Q3_USD":115000.0,"EarningsPerShareBasicAndDiluted_3_Q3_USD":-1.43,"EarningsPerShareBasicAndDiluted_1_Q3_USD":-0.46,"ProfitLoss_3_Q3_USD":-52735000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":2000.0,"StockholdersEquity_0_Q3_USD":131977000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":7022000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":362000.0,"Ticker":"SNDX","CIK":"1395937","name":"SYNDAX PHARMACEUTICALS INC","OfficialName":"Syndax Pharmaceuticals Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"934158860.0","Country":"United States","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NASDAQ","SP500":"nan","filed":"20201105"}]